Cases & Deals

Jefferies International and Kempen complete DKK 998 million share placing by Genmab

Clients Jefferies International Limited and Kempen & Co N.V.

Jones Day advised Jefferies International Limited and Kempen & Co N.V. in connection with the sale of shares in an accelerated book build placing by Genmab A/S, a biotechnology company specializing in the creation and development of differentiated human antibody therapeutics for the treatment of cancer. A total of 4,600,000 shares, equivalent to approximately 9% of the shares in Genmab, were sold at a price of DKK 217 per share, raising total gross proceeds of DKK 998 million (US$182.7 million) for Genmab.